Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
Reads0
Chats0
TLDR
This review summarizes the current literature and presents S. maltophilia as an organism with various molecular mechanisms used for colonization and infection as an emerging multidrug-resistant global opportunistic pathogen.Abstract:
Stenotrophomonas maltophilia is an emerging multidrug-resistant global opportunistic pathogen. The increasing incidence of nosocomial and community-acquired S. maltophilia infections is of particular concern for immunocompromised individuals, as this bacterial pathogen is associated with a significant fatality/case ratio. S. maltophilia is an environmental bacterium found in aqueous habitats, including plant rhizospheres, animals, foods, and water sources. Infections of S. maltophilia can occur in a range of organs and tissues; the organism is commonly found in respiratory tract infections. This review summarizes the current literature and presents S. maltophilia as an organism with various molecular mechanisms used for colonization and infection. S. maltophilia can be recovered from polymicrobial infections, most notably from the respiratory tract of cystic fibrosis patients, as a cocolonizer with Pseudomonas aeruginosa. Recent evidence of cell-cell communication between these pathogens has implications for the development of novel pharmacological therapies. Animal models of S. maltophilia infection have provided useful information about the type of host immune response induced by this opportunistic pathogen. Current and emerging treatments for patients infected with S. maltophilia are discussed.read more
Citations
More filters
Journal ArticleDOI
The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
TL;DR: This article highlights the recent progress obtained for organisms of clinical significance, together with methodological considerations for the characterization of MDR pumps, with particular focus on AcrAB-TolC and Mex pumps.
Journal ArticleDOI
Aminoglycosides: An Overview
TL;DR: Aminoglycosides found widespread use as first-line agents in the early days of antimicrobial chemotherapy, but were eventually replaced in the 1980s with cephalosporins, carbapenems, and fluoroquinolones.
Journal ArticleDOI
β-Lactamases and β-Lactamase Inhibitors in the 21st Century
Catherine L. Tooke,Philip Hinchliffe,Eilis C. Bragginton,Charlotte K. Colenso,Viivi H. A. Hirvonen,Yuiko Takebayashi,James Spencer +6 more
TL;DR: It is contended that issues including continuing unresolved questions around mechanism; opportunities afforded by new technologies such as serial femtosecond crystallography; the need for new inhibitors, particularly for MBLs; the likely impact of new β-lactam:inhibitor combinations and the continuing clinical importance of β- lactams mean that this remains a rewarding research area.
Journal ArticleDOI
Anti-infective properties of epigallocatechin-3-gallate (EGCG), a component of green tea.
TL;DR: This review summarizes the current knowledge and future perspectives on the antibacterial, antifungal and antiviral effects of the green tea constituent EGCG.
Journal ArticleDOI
Epidemiology of β-Lactamase-Producing Pathogens.
Karen Bush,Patricia A. Bradford +1 more
TL;DR: As selective pressure from β-lactam use continues, multiple β-Lactamases per organism are increasingly common, including pathogens carrying three different carbapenemase genes, warranting close attention to increased infection control measures and stewardship of the β- lactam-containing drugs in an effort to control selection of even more deleterious pathogens.
References
More filters
Performance standards for antimicrobial susceptibility testing
TL;DR: The supplemental information presented in this document is intended for use with the antimicrobial susceptibility testing procedures published in the following Clinical and Laboratory Standards Institute (CLSI)–approved standards.
Book
Manual of clinical microbiology
TL;DR: A collaborative team of editors and authors from around the world revised the Manual to include the latest applications of genomics and proteomics, producing an authoritative work of two volumes filled with current findings regarding infectious agents, leading-edge diagnostic methods, laboratory practices, and safety guidelines.
Related Papers (5)
The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants.
Lisa Crossman,Virginia C. Gould,J. Maxwell Dow,Georgios S. Vernikos,Aki Okazaki,Mohammed Sebaihia,David L. Saunders,Claire Arrowsmith,Tim Carver,Nicholas S. Peters,Ellen Adlem,Arnaud Kerhornou,Angela Lord,Lee Murphy,Katharine Seeger,R. Squares,Simon Rutter,Michael A. Quail,Mari Adele Rajandream,David Harris,Carol Churcher,Stephen D. Bentley,Julian Parkhill,Nicholas R. Thomson,Matthew B. Avison +24 more
Stenotrophomonas maltophilia: an emerging opportunist human pathogen.
Microbiological and Clinical Aspects of Infection Associated with Stenotrophomonas maltophilia
Miles Denton,Kevin G. Kerr +1 more